O'Shares Investment Advisers’s Gilead Sciences GILD Stock Holding History

O'Shares Investment Advisers’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-122,288	Closed	-$7.27M	–	91
2022 Q1	$7.27M	Buy	122,288 +6,829	+6%	+$437K	0.57%	39
2021 Q4	$8.38M	Buy	115,459 +8,390	+8%	+$578K	0.6%	40
2021 Q3	$7.48M	Buy	+107,069	New	+$7.52M	0.55%	51
2020 Q3	–	Sell	-22,868	Closed	-$1.76M	–	294
2020 Q2	$1.76M	Sell	22,868 -42,063	-65%	-$3.22M	0.22%	111
2020 Q1	$4.85M	Sell	64,931 -54	-0.1%	-$3.73K	0.87%	28
2019 Q4	$4.22M	Buy	64,985 +4,225	+7%	+$275K	0.58%	44
2019 Q3	$3.85M	Buy	+60,760	New	+$3.97M	0.58%	44

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

O'Shares Investment Advisers's GILD Position: Q2 2022 in Review

O'Shares Investment Advisers sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 122,288 shares — an estimated $7.27M sold.

O'Shares Investment Advisers first reported a position in GILD in Q3 2019 and held it in 7 quarters. The position peaked at $8.38M in Q4 2021. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

O'Shares Investment Advisers reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
O'Shares Investment Advisers sold 122,288 Gilead Sciences shares in Q2 2022, an estimated $7.27M.
O'Shares Investment Advisers first reported a position in Gilead Sciences in Q3 2019 and held it in 7 quarters.
O'Shares Investment Advisers's Gilead Sciences position peaked at $8.38M in Q4 2021.
1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on O'Shares Investment Advisers's 13F filing for Q2 2022.